Oramed Pharmaceuticals
ORMP
ORMP
71 hedge funds and large institutions have $25.5M invested in Oramed Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
19% less funds holding
Funds holding: 88 → 71 (-17)
79% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 19
Holders
71
Holding in Top 10
–
Calls
$3.68M
Puts
$605K
Top Buyers
| 1 | +$508K | |
| 2 | +$460K | |
| 3 | +$419K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$348K |
| 5 |
JSMC
Jess S. Morgan & Co
Los Angeles,
California
|
+$331K |
Top Sellers
| 1 | -$3.51M | |
| 2 | -$3.09M | |
| 3 | -$2.27M | |
| 4 |
Renaissance Technologies
New York
|
-$1.65M |
| 5 |
E
Ergoteles
New York
|
-$1.3M |